Biotechnology
The Biotechnology industry has a total of 595 stocks, with a combined market cap of $1.36 trillion and total revenue of $123.23 billion.
Market Cap
1.36T
Revenue
123.23B
Profits
-32.92B
PE Ratio
n/a
Profit Margin
-26.71%
Dividend Yield
0.04%
595 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 139.61B | 0.65% | 729,629 | 12.95B |
| 2 | MRNA | Moderna, Inc. | 108.87B | 5.85% | 11,325,058 | 2.53B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 92.37B | 1.79% | 548,767 | 16.90B |
| 4 | ARGX | argenx SE | 59.08B | 3.87% | 441,347 | 5.92B |
| 5 | ONC | BeOne Medicines AG | 47.70B | 2.61% | 460,999 | 6.45B |
| 6 | RVMD | Revolution Medicines, Inc. | 43.30B | 4.11% | 2,560,166 | 197.56M |
| 7 | RPRX | Royalty Pharma plc | 39.44B | 2.18% | 3,673,407 | 2.62B |
| 8 | GMAB | Genmab A/S | 36.14B | 4.06% | 4,511,689 | 4.30B |
| 9 | ROIV | Roivant Sciences Ltd. | 29.37B | 4.59% | 12,241,501 | 41.08M |
| 10 | INSM | Insmed Incorporated | 25.47B | 1.46% | 2,666,001 | 1.52B |
| 11 | INCY | Incyte Corporation | 24.85B | 1.88% | 1,154,416 | 6.01B |
| 12 | BNTX | BioNTech SE | 21.70B | - | 1,105,337 | 2.75B |
| 13 | ALNY | Alnylam Pharmaceuticals, Inc. | 20.96B | 0.36% | 3,297,293 | 5.01B |
| 14 | EXEL | Exelixis, Inc. | 17.51B | 3.12% | 4,826,079 | 2.50B |
| 15 | ASND | Ascendis Pharma A/S | 17.07B | 1.18% | 767,717 | 1.20B |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 15.63B | 3.75% | 885,860 | 4.72B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 15.18B | 4.91% | 2,999,529 | 945.54M |
| 18 | SMMT | Summit Therapeutics Inc. | 14.27B | 9.28% | 7,236,228 | - |
| 19 | KYMR | Kymera Therapeutics, Inc. | 11.88B | 5.66% | 1,016,679 | 102.24M |
| 20 | HALO | Halozyme Therapeutics, Inc. | 11.74B | -0.64% | 2,926,332 | 1.80B |
| 21 | TECH | Bio-Techne Corporation | 11.44B | 0.06% | 2,668,038 | 1.23B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 11.09B | 2.14% | 2,050,647 | 3.66B |
| 23 | PCVX | Vaxcyte, Inc. | 10.69B | 5.65% | 889,385 | - |
| 24 | SYRE | Spyre Therapeutics, Inc. | 10.36B | 5.01% | 1,393,579 | - |
| 25 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.06B | 8.32% | 571,311 | 1.43B |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 9.30B | 19.98% | 994,072 | 7.46M |
| 27 | TGTX | TG Therapeutics, Inc. | 8.99B | 5.91% | 4,736,594 | 897.76M |
| 28 | KRYS | Krystal Biotech, Inc. | 8.98B | 0.70% | 281,329 | 470.03M |
| 29 | PTGX | Protagonist Therapeutics, Inc. | 8.89B | 3.14% | 607,105 | 551.69M |
| 30 | TWST | Twist Bioscience Corporation | 8.47B | 11.82% | 1,660,482 | 431.80M |
| 31 | CORT | Corcept Therapeutics Incorporated | 8.21B | 3.11% | 1,653,479 | 963.65M |
| 32 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.89B | 1.39% | 1,286,765 | 280.75M |
| 33 | ABVX | ABIVAX Société Anonyme | 7.71B | 1.66% | 564,125 | 5.33M |
| 34 | CYTK | Cytokinetics, Incorporated | 7.68B | 2.64% | 3,119,050 | 113.29M |
| 35 | IBRX | ImmunityBio, Inc. | 7.53B | -17.72% | 44,733,441 | 182.57M |
| 36 | CAI | Caris Life Sciences, Inc. | 7.34B | 1.39% | 4,902,083 | 1.05B |
| 37 | IMVT | Immunovant, Inc. | 7.26B | 15.13% | 3,977,596 | - |
| 38 | AXSM | Axsome Therapeutics, Inc. | 7.04B | 1.16% | 924,780 | 865.27M |
| 39 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.96B | -15.30% | 8,052,823 | 669.50M |
| 40 | ORKA | Oruka Therapeutics, Inc. | 6.90B | 1.38% | 1,598,666 | - |
| 41 | KOD | Kodiak Sciences Inc. | 6.72B | 7.92% | 1,127,623 | - |
| 42 | CGON | CG Oncology, Inc. | 6.68B | -1.61% | 1,511,579 | 6.17M |
| 43 | BLTE | Belite Bio, Inc | 6.34B | 2.05% | 254,546 | - |
| 44 | LGND | Ligand Pharmaceuticals Incorporated | 6.28B | 2.57% | 137,413 | 253.83M |
| 45 | SRRK | Scholar Rock Holding Corporation | 6.28B | 9.82% | 2,793,455 | - |
| 46 | MIRM | Mirum Pharmaceuticals, Inc. | 6.08B | -0.66% | 709,685 | 670.78M |
| 47 | MANE | Veradermics, Incorporated | 6.01B | 3.67% | 491,913 | - |
| 48 | COGT | Cogent Biosciences, Inc. | 5.84B | 6.02% | 1,680,215 | - |
| 49 | ERAS | Erasca, Inc. | 5.46B | 8.40% | 4,724,244 | - |
| 50 | PTCT | PTC Therapeutics, Inc. | 5.44B | -0.50% | 843,227 | 1.16B |
| 51 | EWTX | Edgewise Therapeutics, Inc. | 5.34B | 8.28% | 2,463,751 | - |
| 52 | IONS | Ionis Pharmaceuticals, Inc. | 5.16B | -21.26% | 18,403,702 | 960.71M |
| 53 | DNTH | Dianthus Therapeutics, Inc. | 5.06B | 4.50% | 596,297 | 2.72M |
| 54 | TVTX | Travere Therapeutics, Inc. | 4.96B | 4.11% | 2,057,940 | 651.03M |
| 55 | CRSP | CRISPR Therapeutics AG | 4.85B | -0.06% | 1,051,822 | 25.17M |
| 56 | DFTX | Definium Therapeutics, Inc. | 4.74B | 6.07% | 1,198,941 | - |
| 57 | LEGN | Legend Biotech Corporation | 4.71B | 3.93% | 2,038,084 | 1.27B |
| 58 | RLAY | Relay Therapeutics, Inc. | 4.50B | 9.57% | 3,319,849 | 10.35M |
| 59 | ABCL | AbCellera Biologics Inc. | 4.05B | 5.13% | 2,873,232 | 66.17M |
| 60 | XENE | Xenon Pharmaceuticals Inc. | 3.91B | 3.19% | 1,538,146 | 7.50M |
| 61 | TNGX | Tango Therapeutics, Inc. | 3.83B | 5.63% | 2,516,735 | 53.81M |
| 62 | ELVN | Enliven Therapeutics, Inc. | 3.79B | 4.29% | 696,749 | - |
| 63 | IOVA | Iovance Biotherapeutics, Inc. | 3.78B | 1.49% | 13,268,405 | 378.98M |
| 64 | PBLS | Parabilis Medicines, Inc. | 3.75B | 6.38% | 950,623 | 148.00K |
| 65 | IRON | Disc Medicine, Inc. | 3.70B | 3.02% | 912,029 | - |
| 66 | VKTX | Viking Therapeutics, Inc. | 3.70B | 7.97% | 4,085,323 | - |
| 67 | TARS | Tarsus Pharmaceuticals, Inc. | 3.49B | 3.27% | 861,078 | 682.20M |
| 68 | DYN | Dyne Therapeutics, Inc. | 3.49B | 3.10% | 3,860,415 | - |
| 69 | CELC | Celcuity Inc. | 3.46B | 5.34% | 782,120 | - |
| 70 | VRDN | Viridian Therapeutics, Inc. | 3.43B | 5.93% | 3,904,613 | 26.31M |
| 71 | TLX | Telix Pharmaceuticals Limited | 3.37B | 2.96% | 398,671 | 890.79M |
| 72 | ARQT | Arcutis Biotherapeutics, Inc. | 3.32B | 2.64% | 2,560,626 | 508.68M |
| 73 | DNLI | Denali Therapeutics Inc. | 3.26B | 1.44% | 1,382,620 | 21.38M |
| 74 | IDYA | IDEAYA Biosciences, Inc. | 3.10B | 2.53% | 854,212 | 36.54M |
| 75 | ZLAB | Zai Lab Limited | 3.02B | 5.46% | 2,072,329 | 441.73M |
| 76 | VCEL | Vericel Corporation | 2.98B | 6.98% | 1,750,206 | 324.17M |
| 77 | XNCR | Xencor, Inc. | 2.90B | 7.92% | 1,955,554 | 200.49M |
| 78 | ACAD | Acadia Pharmaceuticals Inc. | 2.85B | -22.40% | 11,999,867 | 1.20B |
| 79 | ADMA | ADMA Biologics, Inc. | 2.84B | 0.43% | 3,364,142 | 519.15M |
| 80 | RCUS | Arcus Biosciences, Inc. | 2.73B | 3.56% | 702,714 | 100.00M |
| 81 | BEAM | Beam Therapeutics Inc. | 2.70B | 2.39% | 1,287,984 | 146.64M |
| 82 | MBX | MBX Biosciences, Inc. | 2.60B | 5.20% | 666,073 | - |
| 83 | PVLA | Palvella Therapeutics, Inc. | 2.56B | -0.48% | 361,477 | - |
| 84 | CLDX | Celldex Therapeutics, Inc. | 2.45B | 4.62% | 1,591,697 | 158.00K |
| 85 | PHVS | Pharvaris N.V. | 2.42B | 0.41% | 638,320 | - |
| 86 | RXRX | Recursion Pharmaceuticals, Inc. | 2.38B | 8.24% | 20,311,844 | 68.23M |
| 87 | SEPN | Septerna, Inc. | 2.37B | 3.87% | 713,673 | 98.88M |
| 88 | VIR | Vir Biotechnology, Inc. | 2.34B | 11.67% | 7,116,143 | 302.80M |
| 89 | BHVN | Biohaven Ltd. | 2.30B | 5.11% | 3,589,582 | - |
| 90 | IMNM | Immunome, Inc. | 2.29B | 3.53% | 1,156,034 | 4.02M |
| 91 | NAMS | NewAmsterdam Pharma Company N.V. | 2.27B | 0.34% | 2,762,174 | 25.94M |
| 92 | AUPH | Aurinia Pharmaceuticals Inc. | 2.23B | 1.00% | 682,249 | 321.74M |
| 93 | VERA | Vera Therapeutics, Inc. | 2.21B | 2.74% | 1,392,014 | 10.28M |
| 94 | ZYME | Zymeworks Inc. | 2.19B | 4.05% | 1,106,808 | 37.13M |
| 95 | TRVI | Trevi Therapeutics, Inc. | 2.19B | 7.05% | 1,410,313 | - |
| 96 | LKFT | Lakefront Biotherapeutics NV | 2.15B | 0.39% | 313,396 | 1.13B |
| 97 | FTRE | Fortrea Holdings Inc. | 2.15B | 1.23% | 1,040,478 | 2.67B |
| 98 | REPL | Replimune Group, Inc. | 2.11B | 3.01% | 3,204,109 | - |
| 99 | TRAX | First Tracks Biotherapeutics, Inc. | 2.09B | 3.78% | 808,161 | - |
| 100 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.08B | 6.65% | 2,146,198 | 213.00M |
| 101 | COAG | Hemab Therapeutics Holdings, Inc. | 1.99B | -12.96% | 1,095,691 | - |
| 102 | HRMY | Harmony Biosciences Holdings, Inc. | 1.98B | 1.96% | 792,898 | 989.36M |
| 103 | ZBIO | Zenas BioPharma, Inc. | 1.93B | 0.85% | 445,850 | 11.00M |
| 104 | MAZE | Maze Therapeutics, Inc. | 1.88B | 1.96% | 510,308 | 20.00M |
| 105 | AGIO | Agios Pharmaceuticals, Inc. | 1.88B | 6.60% | 1,341,834 | 140.84M |
| 106 | MESO | Mesoblast Limited | 1.86B | 1.47% | 83,054 | 120.25M |
| 107 | ABSI | Absci Corporation | 1.85B | 6.15% | 3,747,094 | 1.56M |
| 108 | SRPT | Sarepta Therapeutics, Inc. | 1.85B | -3.28% | 2,470,012 | 1.96B |
| 109 | GENB | Generate Biomedicines, Inc. | 1.82B | 8.61% | 664,217 | 26.48M |
| 110 | STOK | Stoke Therapeutics, Inc. | 1.81B | 4.45% | 1,057,480 | 28.21M |
| 111 | NVAX | Novavax, Inc. | 1.80B | 0.93% | 7,809,307 | 411.65M |
| 112 | KLRA | Kailera Therapeutics, Inc. | 1.79B | 6.13% | 1,366,416 | - |
| 113 | NRIX | Nurix Therapeutics, Inc. | 1.76B | 5.42% | 5,974,103 | 701.94M |
| 114 | LYCA | Lycia Therapeutics, Inc. | 1.75B | -0.33% | 184,429 | 4.44M |
| 115 | SLS | SELLAS Life Sciences Group, Inc. | 1.73B | 1.90% | 4,754,687 | - |
| 116 | NTLA | Intellia Therapeutics, Inc. | 1.70B | 6.61% | 2,945,659 | 52.89M |
| 117 | PGEN | Precigen, Inc. | 1.69B | 5.48% | 8,811,452 | 156.94M |
| 118 | RARE | Ultragenyx Pharmaceutical Inc. | 1.67B | 6.42% | 2,668,970 | 730.00M |
| 119 | IMCR | Immunocore Holdings plc | 1.64B | 2.45% | 554,353 | 429.30M |
| 120 | NBTX | Nanobiotix S.A. | 1.62B | 4.83% | 170,419 | 13.15M |
| 121 | QURE | uniQure N.V. | 1.60B | 5.12% | 1,294,686 | 20.17M |
| 122 | BRVE | Braveheart Bio, Inc. | 1.58B | 4.19% | 618,347 | - |
| 123 | RAPP | Rapport Therapeutics, Inc. | 1.54B | 6.59% | 788,743 | 20.00M |
| 124 | ADRX | ADARx Pharmaceuticals, Inc. | 1.54B | 4.08% | 320,118 | 6.13M |
| 125 | TYRA | Tyra Biosciences, Inc. | 1.53B | 5.25% | 271,559 | - |
| 126 | NUVB | Nuvation Bio Inc. | 1.53B | 4.09% | 4,580,406 | 201.73M |
| 127 | GPCR | Structure Therapeutics Inc. | 1.53B | 5.21% | 1,173,087 | - |
| 128 | OCUL | Ocular Therapeutix, Inc. | 1.51B | 4.09% | 3,554,781 | 50.38M |
| 129 | DMRA | Damora Therapeutics, Inc. | 1.49B | 1.65% | 564,142 | - |
| 130 | LBRX | LB Pharmaceuticals Inc | 1.46B | 7.21% | 472,299 | - |
| 131 | ANAB | AnaptysBio, Inc. | 1.44B | 3.38% | 323,838 | 106.09M |
| 132 | TSHA | Taysha Gene Therapies, Inc. | 1.43B | 1.15% | 3,142,010 | 5.49M |
| 133 | KARD | Kardigan, Inc. | 1.42B | -2.19% | 339,102 | - |
| 134 | KRSA | Korsana Biosciences, Inc. | 1.41B | -0.19% | 159,939 | - |
| 135 | MLYS | Mineralys Therapeutics, Inc. | 1.40B | 3.00% | 2,959,775 | - |
| 136 | AAPG | Ascentage Pharma Group International | 1.39B | -0.45% | 5,157 | 94.61M |
| 137 | INVA | Innoviva, Inc. | 1.35B | -0.65% | 1,661,112 | 438.32M |
| 138 | INBX | Inhibrx Biosciences, Inc. | 1.35B | 8.40% | 185,720 | 1.30M |
| 139 | MNKD | MannKind Corporation | 1.35B | 7.31% | 4,818,124 | 413.37M |
| 140 | GHRS | GH Research PLC | 1.33B | 4.14% | 172,671 | - |
| 141 | AVLN | Avalyn Pharma Inc. | 1.30B | 0.93% | 697,391 | - |
| 142 | DRTS | Alpha Tau Medical Ltd. | 1.30B | 2.62% | 486,522 | - |
| 143 | URGN | UroGen Pharma Ltd. | 1.29B | 6.38% | 1,422,500 | 250.25M |
| 144 | NKTR | Nektar Therapeutics | 1.29B | 1.45% | 608,166 | 54.59M |
| 145 | SGP | SpyGlass Pharma, Inc. | 1.28B | 3.78% | 226,589 | - |
| 146 | SVRA | Savara Inc. | 1.28B | 4.24% | 2,038,830 | - |
| 147 | OMER | Omeros Corporation | 1.27B | 3.90% | 764,620 | 38.42M |
| 148 | SLN | Silence Therapeutics plc | 1.23B | 0.13% | 1,377,346 | 615.00K |
| 149 | VOR | Vor Biopharma Inc. | 1.22B | 0.25% | 1,095,633 | - |
| 150 | SPTX | Seaport Therapeutics, Inc. | 1.19B | 3.21% | 306,863 | - |
| 151 | VSTM | Verastem, Inc. | 1.10B | 3.33% | 2,754,330 | 100.30M |
| 152 | ANRO | Alto Neuroscience, Inc. | 1.09B | 10.19% | 824,850 | - |
| 153 | MLTX | MoonLake Immunotherapeutics | 1.08B | 9.71% | 1,579,403 | - |
| 154 | JBIO | Jade Biosciences, Inc. | 991.80M | 3.48% | 739,448 | - |
| 155 | PHAR | Pharming Group N.V. | 967.01M | 6.18% | 19,690 | 386.75M |
| 156 | CRVS | Corvus Pharmaceuticals, Inc. | 958.67M | 7.83% | 1,271,153 | - |
| 157 | ORIC | ORIC Pharmaceuticals, Inc. | 955.68M | 4.54% | 1,192,156 | - |
| 158 | CTY | City Therapeutics, Inc. | 931.45M | 2.58% | 214,301 | 14.34M |
| 159 | ODTX | Odyssey Therapeutics, Inc. | 916.63M | -0.57% | 562,651 | 99.00K |
| 160 | MGTX | MeiraGTx Holdings plc | 910.97M | 5.39% | 454,888 | 397.50M |
| 161 | AKTS | Aktis Oncology, Inc. | 908.27M | 3.22% | 468,056 | 10.06M |
| 162 | IVA | Inventiva S.A. | 905.13M | 1.05% | 1,568,833 | 2.81M |
| 163 | GLUE | Monte Rosa Therapeutics, Inc. | 903.21M | - | 1,357,106 | 70.33M |
| 164 | IMTX | Immatics N.V. | 878.23M | 1.02% | 661,390 | 47.65M |
| 165 | LTGO | Latigo Biotherapeutics, Inc. | 877.80M | 5.08% | 326,381 | - |
| 166 | BBTX | Bambusa Therapeutics, Inc. | 866.02M | 8.07% | 291,974 | - |
| 167 | SNDX | Syndax Pharmaceuticals, Inc. | 859.32M | 0.05% | 2,665,116 | 289.68M |
| 168 | OBX | Obsidian Therapeutics, Inc. | 849.38M | -0.83% | 1,143,732 | - |
| 169 | ALMS | Alumis Inc. | 846.51M | 8.46% | 2,405,486 | 7.40M |
| 170 | DNA | Ginkgo Bioworks Holdings, Inc. | 833.00M | 9.57% | 2,908,261 | 130.75M |
| 171 | LXRX | Lexicon Pharmaceuticals, Inc. | 805.87M | 1.69% | 2,529,092 | 38.54M |
| 172 | ANNX | Annexon, Inc. | 801.92M | 0.71% | 2,815,341 | - |
| 173 | AURA | Aura Biosciences, Inc. | 795.42M | 16.92% | 1,050,820 | - |
| 174 | RIGL | Rigel Pharmaceuticals, Inc. | 789.54M | 5.75% | 310,218 | 288.21M |
| 175 | SLDB | Solid Biosciences Inc. | 782.95M | 6.45% | 2,373,287 | - |
| 176 | JANX | Janux Therapeutics, Inc. | 780.70M | -27.62% | 4,462,476 | 23.29M |
| 177 | OABI | OmniAb, Inc. | 770.87M | 5.07% | 2,467,331 | 40.21M |
| 178 | SGMT | Sagimet Biosciences Inc. | 769.36M | 10.15% | 1,093,246 | - |
| 179 | PRME | Prime Medicine, Inc. | 764.10M | -7.63% | 3,475,026 | 4.07M |
| 180 | CGEM | Cullinan Therapeutics, Inc. | 752.95M | 3.45% | 1,034,134 | - |
| 181 | ATTO | Attovia Therapeutics, Inc. | 739.55M | 6.09% | 279,021 | 1.80M |
| 182 | ARDX | Ardelyx, Inc. | 736.52M | 1.74% | 5,780,124 | 468.22M |
| 183 | ABUS | Arbutus Biopharma Corporation | 735.99M | 1.78% | 1,709,133 | 181.72M |
| 184 | SANA | Sana Biotechnology, Inc. | 734.11M | 3.38% | 2,894,420 | - |
| 185 | CADL | Candel Therapeutics, Inc. | 728.07M | 8.74% | 1,369,372 | - |
| 186 | ZVRA | Zevra Therapeutics, Inc. | 722.98M | 4.83% | 1,893,463 | 147.76M |
| 187 | ANL | Adlai Nortye Group Ltd. | 717.39M | 8.37% | 263,352 | 18.06M |
| 188 | NVCT | Nuvectis Pharma, Inc. | 717.35M | -0.24% | 385,116 | - |
| 189 | IMMX | Immix Biopharma, Inc. | 711.31M | 6.45% | 1,270,819 | - |
| 190 | AVBP | ArriVent BioPharma, Inc. | 698.20M | 3.81% | 905,949 | - |
| 191 | ACHV | Achieve Life Sciences, Inc. | 696.65M | 0.74% | 1,087,876 | - |
| 192 | DSGN | Design Therapeutics, Inc. | 692.23M | 5.88% | 313,907 | - |
| 193 | FDMT | 4D Molecular Therapeutics, Inc. | 688.90M | 1.80% | 879,601 | 92.01M |
| 194 | WVE | Wave Life Sciences, Inc. | 685.37M | 3.27% | 3,934,545 | 70.92M |
| 195 | HELP | Helus Pharma Inc. | 683.84M | 4.46% | 1,584,429 | - |
| 196 | ACRS | Aclaris Therapeutics, Inc. | 674.10M | 8.97% | 2,027,564 | 6.40M |
| 197 | KURA | Kura Oncology, Inc. | 672.54M | 3.99% | 2,099,082 | 77.23M |
| 198 | DBVT | DBV Technologies S.A. | 666.14M | 5.93% | 411,303 | 3.74M |
| 199 | BCAX | Bicara Therapeutics Inc. | 661.07M | 15.49% | 1,833,045 | - |
| 200 | APMD | Apnimed, Inc. | 659.85M | 4.97% | 276,286 | 115.12M |
| 201 | CLYM | Climb Bio, Inc. | 646.12M | 6.90% | 1,783,649 | - |
| 202 | OLMA | Olema Pharmaceuticals, Inc. | 643.11M | 0.27% | 1,516,460 | - |
| 203 | GERN | Geron Corporation | 638.12M | 0.07% | 4,898,145 | 217.52M |
| 204 | IAM | Iambic Therapeutics, Inc. | 630.43M | 30.78% | 844,944 | 18.25M |
| 205 | CBIO | Crescent Biopharma, Inc. | 591.51M | 2.07% | 204,646 | 11.88M |
| 206 | CAPR | Capricor Therapeutics, Inc. | 572.67M | 9.44% | 4,697,443 | 11.13M |
| 207 | VALN | Valneva SE | 566.64M | 2.72% | 9,189 | 163.30M |
| 208 | ENTX | Entera Bio Ltd. | 563.51M | 3.18% | 512,162 | 42.00K |
| 209 | SLBT | SL Science Holding Limited | 562.11M | 5.14% | 10,549 | 3.27M |
| 210 | SRZN | Surrozen, Inc. | 561.94M | 3.61% | 120,648 | 11.51M |
| 211 | OVID | Ovid Therapeutics Inc. | 555.62M | -0.18% | 5,189,815 | 1.58M |
| 212 | RGNX | REGENXBIO Inc. | 534.60M | 6.10% | 2,173,999 | 153.91M |
| 213 | NGNE | Neurogene Inc. | 521.10M | 2.88% | 441,722 | 925.00K |
| 214 | DMAC | DiaMedica Therapeutics Inc. | 519.84M | 2.99% | 144,501 | - |
| 215 | ETRA | Electra Therapeutics, Inc. | 508.73M | 3.91% | 428,270 | - |
| 216 | STTK | Shattuck Labs, Inc. | 508.19M | 8.01% | 1,262,519 | 1.00M |
| 217 | GYRE | Gyre Therapeutics, Inc. | 501.29M | -3.78% | 224,593 | 110.06M |
| 218 | MNPR | Monopar Therapeutics Inc. | 492.07M | 2.65% | 124,678 | - |
| 219 | EPRX | Eupraxia Pharmaceuticals Inc. | 488.86M | 7.69% | 566,776 | - |
| 220 | MDXG | MiMedx Group, Inc. | 485.20M | 0.45% | 868,750 | 303.73M |
| 221 | YDES | YD Bio Limited | 483.07M | 14.24% | 40,154 | 1.24M |
| 222 | OCS | Oculis Holding AG | 482.13M | 4.27% | 339,262 | 1.12M |
| 223 | INDP | Indaptus Therapeutics, Inc. | 479.17M | -6.02% | 189,796 | - |
| 224 | BLSM | BlossomHill Therapeutics, Inc. | 456.75M | 6.44% | 213,183 | - |
| 225 | PRTA | Prothena Corporation plc | 450.85M | 10.16% | 741,116 | 52.74M |
| 226 | RLMD | Relmada Therapeutics, Inc. | 442.68M | 6.41% | 958,590 | - |
| 227 | ARVN | Arvinas, Inc. | 442.68M | 5.46% | 1,029,645 | 275.30M |
| 228 | ASMB | Assembly Biosciences, Inc. | 442.64M | 6.46% | 313,286 | 74.85M |
| 229 | OBIO | Orchestra BioMed Holdings, Inc. | 435.78M | 0.35% | 781,610 | 31.98M |
| 230 | PBYI | Puma Biotechnology, Inc. | 435.16M | 2.18% | 748,365 | 231.87M |
| 231 | CRMD | CorMedix Inc. | 427.91M | 3.20% | 2,323,834 | 462.25M |
| 232 | CTMX | CytomX Therapeutics, Inc. | 426.20M | -10.73% | 12,903,614 | 14.03M |
| 233 | TECX | Tectonic Therapeutic, Inc. | 425.88M | 5.55% | 129,555 | - |
| 234 | PHAT | Phathom Pharmaceuticals, Inc. | 423.36M | 1.52% | 1,938,580 | 274.88M |
| 235 | EDIT | Editas Medicine, Inc. | 423.11M | 7.20% | 3,299,772 | 49.83M |
| 236 | AVTX | Avalo Therapeutics, Inc. | 420.08M | 4.83% | 2,630,523 | 59.00K |
| 237 | CCCC | C4 Therapeutics, Inc. | 411.68M | 1.13% | 2,388,734 | 32.28M |
| 238 | ALT | Altimmune, Inc. | 410.43M | 1.44% | 4,358,401 | 31.00K |
| 239 | RZLT | Rezolute, Inc. | 407.03M | - | 2,233,907 | - |
| 240 | MPLT | MapLight Therapeutics, Inc. | 405.15M | 5.19% | 458,792 | - |
| 241 | CTNM | Contineum Therapeutics, Inc. | 402.87M | 7.77% | 264,400 | - |
| 242 | PRLD | Prelude Therapeutics Incorporated | 386.23M | 4.17% | 230,958 | 22.42M |
| 243 | LYEL | Lyell Immunopharma, Inc. | 379.85M | 3.97% | 409,837 | 15.00K |
| 244 | FENC | Fennec Pharmaceuticals Inc. | 379.60M | 10.35% | 245,009 | 59.22M |
| 245 | ALLO | Allogene Therapeutics, Inc. | 372.45M | 3.37% | 10,683,141 | 4.64M |
| 246 | DTIL | Precision BioSciences, Inc. | 368.35M | -8.96% | 589,675 | 45.04M |
| 247 | AGMB | AgomAb Therapeutics NV | 367.88M | -2.16% | 661,382 | - |
| 248 | ALEC | Alector, Inc. | 366.98M | 7.64% | 2,095,591 | 173.47M |
| 249 | ASPE | Aspen Neuroscience, Inc. | 366.39M | 1.29% | 215,456 | - |
| 250 | TRXB | TRex Bio, Inc. | 354.56M | -0.68% | 171,558 | - |
| 251 | AVIR | Atea Pharmaceuticals, Inc. | 354.50M | 2.55% | 244,167 | - |
| 252 | IRD | Opus Genetics, Inc. | 350.25M | 0.72% | 1,145,648 | 9.86M |
| 253 | PROK | ProKidney Corp. | 349.18M | 1.32% | 1,464,913 | 818.00K |
| 254 | GALT | Galectin Therapeutics Inc. | 348.94M | 10.19% | 241,182 | - |
| 255 | AUTL | Autolus Therapeutics plc | 348.67M | 2.34% | 4,456,022 | 117.39M |
| 256 | BNTC | Benitec Biopharma Inc. | 343.59M | 3.25% | 432,760 | - |
| 257 | XFOR | X4 Pharmaceuticals, Inc. | 339.02M | 4.40% | 891,254 | 16.96M |
| 258 | VCRE | Vicore Pharma Holding AB (publ) | 335.96M | 8.37% | 8,494 | 383.48K |
| 259 | ENTA | Enanta Pharmaceuticals, Inc. | 333.49M | 4.09% | 351,777 | 65.26M |
| 260 | OCGN | Ocugen, Inc. | 330.28M | 5.23% | 8,797,555 | 4.78M |
| 261 | FTH | Faeth Therapeutics, Inc. | 327.40M | -42.54% | 3,962,084 | - |
| 262 | IPSC | Century Therapeutics, Inc. | 326.84M | 7.44% | 1,460,031 | 109.16M |
| 263 | AGEN | Agenus Inc. | 323.97M | 0.14% | 838,629 | 133.95M |
| 264 | CABA | Cabaletta Bio, Inc. | 322.50M | 15.00% | 8,160,905 | - |
| 265 | KYTX | Kyverna Therapeutics, Inc. | 319.73M | 5.94% | 743,476 | - |
| 266 | SPRY | ARS Pharmaceuticals, Inc. | 317.17M | 13.08% | 3,185,266 | 122.14M |
| 267 | SCTX | Scribe Therapeutics Inc. | 315.97M | 6.31% | 304,832 | 33.30M |
| 268 | EIKN | Eikon Therapeutics, Inc. | 315.24M | -1.36% | 722,193 | - |
| 269 | IKT | Inhibikase Therapeutics, Inc. | 304.98M | 11.67% | 558,723 | 1.00 |
| 270 | NAUT | Nautilus Biotechnology, Inc. | 303.15M | 6.73% | 4,080,983 | 424.00K |
| 271 | CAMP | Camp4 Therapeutics Corporation | 291.18M | 14.29% | 373,948 | 5.32M |
| 272 | TTRX | Turn Therapeutics Inc. | 289.24M | 2.43% | 132,089 | - |
| 273 | FULC | Fulcrum Therapeutics, Inc. | 283.44M | 0.41% | 1,295,902 | 80.00M |
| 274 | SABS | SAB Biotherapeutics, Inc. | 280.18M | 2.64% | 790,076 | 114.70K |
| 275 | QTTB | Q32 Bio Inc. | 280.09M | 1.19% | 413,222 | 53.74M |
| 276 | RCKT | Rocket Pharmaceuticals, Inc. | 278.83M | 6.50% | 1,753,549 | - |
| 277 | EVMN | Evommune, Inc. | 278.36M | 15.34% | 740,591 | 10.00M |
| 278 | LCTX | Lineage Cell Therapeutics, Inc. | 275.67M | 6.86% | 894,173 | 13.08M |
| 279 | ARCT | Arcturus Therapeutics Holdings Inc. | 274.10M | -8.12% | 913,906 | 30.51M |
| 280 | VOGX | Vogenx, Inc. | 271.85M | 4.87% | 217,859 | - |
| 281 | CUVL | Clinuvel Pharmaceuticals Limited | 266.63M | 1.57% | 6,934 | 65.05M |
| 282 | LRMR | Larimar Therapeutics, Inc. | 264.61M | 6.07% | 689,314 | - |
| 283 | BCYC | Bicycle Therapeutics plc | 263.55M | 4.16% | 590,235 | 83.53M |
| 284 | VTVT | vTv Therapeutics Inc. | 263.15M | 0.71% | 12,393 | 36.84M |
| 285 | LXEO | Lexeo Therapeutics, Inc. | 258.02M | 8.82% | 1,336,057 | - |
| 286 | INO | Inovio Pharmaceuticals, Inc. | 255.08M | 24.28% | 31,046,233 | 65.34K |
| 287 | VNDA | Vanda Pharmaceuticals Inc. | 247.93M | 7.33% | 1,670,205 | 229.28M |
| 288 | GLSI | Greenwich LifeSciences, Inc. | 246.45M | 10.68% | 155,774 | - |
| 289 | ACIU | AC Immune SA | 243.60M | 9.87% | 469,279 | 23.75M |
| 290 | IMRX | Immuneering Corporation | 236.39M | -0.82% | 849,062 | - |
| 291 | ELDN | Eledon Pharmaceuticals, Inc. | 232.64M | 9.79% | 977,361 | - |
| 292 | FATE | Fate Therapeutics, Inc. | 232.45M | 5.72% | 2,213,355 | 4.75M |
| 293 | RNAC | Cartesian Therapeutics, Inc. | 213.67M | -6.97% | 313,213 | 1.03M |
| 294 | PALI | Palisade Bio, Inc. | 207.38M | 5.31% | 1,405,590 | 500.00K |
| 295 | ARTV | Artiva Biotherapeutics, Inc. | 206.32M | 1.69% | 939,951 | 251.00K |
| 296 | PLX | Protalix BioTherapeutics, Inc. | 206.26M | 0.79% | 791,786 | 80.62M |
| 297 | KRRO | Korro Bio, Inc. | 204.37M | 0.95% | 175,517 | 1.29M |
| 298 | MDWD | MediWound Ltd. | 202.92M | -0.35% | 268,387 | 11.86M |
| 299 | SLGL | Sol-Gel Technologies Ltd. | 202.14M | 1.20% | 18,383 | 1.80M |
| 300 | PYXS | Pyxis Oncology, Inc. | 201.88M | 1.81% | 880,088 | 11.04M |
| 301 | CGEN | Compugen Ltd. | 201.76M | 8.67% | 289,115 | 75.93M |
| 302 | UPB | Upstream Bio, Inc. | 195.53M | 10.53% | 1,983,546 | 3.16M |
| 303 | PRQR | ProQR Therapeutics N.V. | 194.75M | 2.22% | 276,576 | 21.05M |
| 304 | ACOG | Alpha Cognition Inc. | 194.48M | 7.72% | 105,829 | 15.26M |
| 305 | IFRX | InflaRx N.V. | 191.58M | -0.38% | 449,243 | -38.53K |
| 306 | DRUG | Bright Minds Biosciences Inc. | 191.54M | 4.50% | 84,237 | - |
| 307 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 185.20M | 13.24% | 779,794 | - |
| 308 | WHWK | Whitehawk Therapeutics, Inc. | 182.14M | 2.08% | 1,153,663 | 7.15M |
| 309 | KROS | Keros Therapeutics, Inc. | 179.17M | -2.46% | 144,123 | 40.76M |
| 310 | IVVD | Invivyd, Inc. | 177.71M | 7.09% | 2,900,059 | 58.37M |
| 311 | ALXO | ALX Oncology Holdings Inc. | 176.30M | 10.39% | 1,030,186 | - |
| 312 | STRO | Sutro Biopharma, Inc. | 175.76M | 10.19% | 268,509 | 45.70M |
| 313 | TRDA | Entrada Therapeutics, Inc. | 171.03M | -4.19% | 500,223 | 3.98M |
| 314 | PEPG | PepGen Inc. | 166.22M | -2.83% | 1,364,088 | - |
| 315 | ORMP | Oramed Pharmaceuticals Inc. | 165.97M | 3.37% | 94,541 | 2.00M |
| 316 | ZNTL | Zentalis Pharmaceuticals, Inc. | 163.31M | 0.29% | 1,269,693 | 26.87M |
| 317 | SION | Sionna Therapeutics, Inc. | 161.41M | 8.84% | 1,089,208 | - |
| 318 | MSLE | Satellos Bioscience Inc. | 158.02M | 3.76% | 30,995 | - |
| 319 | TARA | Protara Therapeutics, Inc. | 154.85M | 9.35% | 914,741 | - |
| 320 | CNTN | Canton Strategic Holdings, Inc. | 154.58M | -5.83% | 603,135 | 1.50M |
| 321 | CUE | Cue Biopharma, Inc. | 151.10M | 11.05% | 179,632 | 37.66M |
| 322 | ANTX | AN2 Therapeutics, Inc. | 150.94M | - | 496,679 | - |
| 323 | NGEN | NervGen Pharma Corp. | 150.53M | 5.26% | 338,184 | - |
| 324 | CMPX | Compass Therapeutics, Inc. | 149.89M | 9.69% | 2,227,497 | 850.00K |
| 325 | MGNX | MacroGenics, Inc. | 148.74M | 0.21% | 953,352 | 175.14M |
| 326 | YARW | Yarrow Bioscience, Inc. | 147.29M | 1.47% | 95,398 | - |
| 327 | VRXA | Veraxa Biotech AG | 146.36M | 8.95% | 171,879 | 29.54K |
| 328 | ABEO | Abeona Therapeutics Inc. | 144.96M | -39.21% | 13,390,466 | 39.01M |
| 329 | RNA | Atrium Therapeutics, Inc. | 143.35M | 0.48% | 117,110 | 35.84M |
| 330 | SPRB | Spruce Biosciences, Inc. | 143.30M | 7.11% | 135,064 | 697.00K |
| 331 | ADAG | Adagene Inc. | 142.34M | 6.00% | 157,181 | 9.29M |
| 332 | ARMP | Armata Pharmaceuticals, Inc. | 140.92M | 7.98% | 88,301 | 5.54M |
| 333 | IPHA | Innate Pharma S.A. | 139.95M | 2.08% | 17,341 | 11.21M |
| 334 | MENS | Jyong Biotech Ltd. | 136.22M | 1.94% | 74,950 | - |
| 335 | LENZ | LENZ Therapeutics, Inc. | 134.95M | 22.71% | 1,538,670 | 12.36M |
| 336 | NERV | Minerva Neurosciences, Inc. | 131.07M | 8.68% | 348,311 | - |
| 337 | OKUR | OnKure Therapeutics, Inc. | 130.01M | 12.04% | 814,191 | - |
| 338 | CHRS | Coherus Oncology, Inc. | 126.20M | 6.08% | 2,157,799 | 50.94M |
| 339 | PYPD | PolyPid Ltd. | 125.93M | 0.98% | 258,881 | - |
| 340 | HUMA | Humacyte, Inc. | 125.79M | 1.03% | 5,482,045 | 2.12M |
| 341 | VYGR | Voyager Therapeutics, Inc. | 123.84M | 6.70% | 1,810,362 | 25.11M |
| 342 | CDXS | Codexis, Inc. | 121.55M | 2.78% | 792,941 | 77.68M |
| 343 | FHTX | Foghorn Therapeutics Inc. | 121.15M | 9.09% | 1,393,795 | 112.13M |
| 344 | EQ | Equillium, Inc. | 119.12M | 0.66% | 213,287 | 4.39M |
| 345 | ZURA | Zura Bio Limited | 118.96M | -69.80% | 63,742,944 | - |
| 346 | ENGN | enGene Therapeutics Inc. | 118.62M | 1.14% | 848,598 | - |
| 347 | MOLN | Molecular Partners AG | 116.87M | -3.89% | 972 | 856.30K |
| 348 | AVXL | Anavex Life Sciences Corp. | 114.02M | 6.96% | 656,757 | - |
| 349 | NKTX | Nkarta, Inc. | 114.01M | -8.09% | 9,104,838 | - |
| 350 | OTLK | Outlook Therapeutics, Inc. | 110.84M | 4.33% | 1,921,121 | -1.16M |
| 351 | IMUX | Immunic, Inc. | 109.29M | 3.35% | 259,940 | - |
| 352 | ANIX | Anixa Biosciences, Inc. | 108.81M | -1.42% | 126,706 | - |
| 353 | BDTX | Black Diamond Therapeutics, Inc. | 106.29M | 6.63% | 728,074 | 70.00M |
| 354 | NBP | NovaBridge Biosciences | 105.15M | -0.33% | 241,972 | - |
| 355 | HURA | TuHURA Biosciences, Inc. | 105.15M | 1.23% | 404,706 | - |
| 356 | MIST | Milestone Pharmaceuticals Inc. | 104.57M | -2.71% | 2,634,417 | 2.34M |
| 357 | UNCY | Unicycive Therapeutics, Inc. | 102.65M | 3.80% | 784,718 | - |
| 358 | NRXP | NRx Pharmaceuticals, Inc. | 102.53M | -0.42% | 856,783 | 3.39M |
| 359 | KZIA | Kazia Therapeutics Limited | 101.13M | 2.79% | 123,537 | 1.27M |
| 360 | VANI | Vivani Medical, Inc. | 100.58M | 4.21% | 102,204 | - |
| 361 | RTSN | Retension Pharmaceuticals, Inc. | 99.65M | 8.33% | 306,423 | - |
| 362 | PLYX | Polaryx Therapeutics, Inc. | 95.95M | 6.94% | 30,493 | - |
| 363 | TENX | Tenax Therapeutics, Inc. | 95.15M | 5.03% | 1,504,634 | - |
| 364 | ICCC | ImmuCell Corporation | 94.45M | 6.12% | 6,264 | 30.68M |
| 365 | PMVP | PMV Pharmaceuticals, Inc. | 94.39M | -0.79% | 188,319 | - |
| 366 | GNLX | Genelux Corporation | 92.76M | 5.61% | 233,978 | 8.00K |
| 367 | NTHI | NeOnc Technologies Holdings, Inc. | 91.97M | 6.02% | 316,175 | 39.99K |
| 368 | SEER | Seer, Inc. | 91.36M | 1.23% | 99,305 | 14.22M |
| 369 | NMRA | Neumora Therapeutics, Inc. | 91.32M | -3.44% | 674,717 | - |
| 370 | TVGN | Tevogen Inc. | 90.33M | 2.68% | 2,621 | - |
| 371 | CBUS | Cibus, Inc. | 89.42M | -0.85% | 51,099 | 4.35M |
| 372 | TNYA | Tenaya Therapeutics, Inc. | 87.45M | 8.27% | 2,921,674 | 3.03M |
| 373 | CLLS | Cellectis S.A. | 86.79M | 6.54% | 33,411 | 63.82M |
| 374 | TLSA | Tiziana Life Sciences Ltd | 85.79M | -2.71% | 301,373 | - |
| 375 | RLYB | Rallybio Corporation | 83.88M | -1.08% | 25,930 | 434.00K |
| 376 | ATRA | Atara Biotherapeutics, Inc. | 82.11M | 3.94% | 13,531 | 6.19M |
| 377 | RANI | Rani Therapeutics Holdings, Inc. | 79.89M | 4.81% | 361,049 | 4.88M |
| 378 | NRXS | NeurAxis, Inc. | 79.37M | 1.28% | 142,279 | 6.53M |
| 379 | COYA | Coya Therapeutics, Inc. | 78.35M | 11.71% | 181,160 | 8.02M |
| 380 | PDSB | PDS Biotechnology Corporation | 77.91M | -12.60% | 4,004,630 | - |
| 381 | TNXP | Tonix Pharmaceuticals Holding Corp. | 77.01M | -5.27% | 1,445,566 | 43.05M |
| 382 | MNOV | MediciNova, Inc. | 71.86M | - | 53,872 | 920.48K |
| 383 | NTRB | Nutriband Inc. | 71.84M | 6.49% | 20,334 | 1.62M |
| 384 | CNXU | Conexeu Sciences Inc. | 70.60M | 1.33% | 219,819 | - |
| 385 | HRTX | Heron Therapeutics, Inc. | 69.68M | 25.26% | 137,124,444 | 148.22M |
| 386 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 68.27M | 14.98% | 1,239,313 | - |
| 387 | CSBR | Champions Oncology, Inc. | 67.37M | 1.04% | 1,938 | 60.66M |
| 388 | ACRV | Acrivon Therapeutics, Inc. | 67.28M | -2.48% | 226,575 | - |
| 389 | OKYO | OKYO Pharma Limited | 67.17M | -10.49% | 118,415 | - |
| 390 | GOSS | Gossamer Bio, Inc. | 66.67M | 11.57% | 232,179 | 53.29M |
| 391 | MAIA | MAIA Biotechnology, Inc. | 66.60M | 3.30% | 225,328 | - |
| 392 | CGTX | Cognition Therapeutics, Inc. | 66.39M | 1.63% | 405,865 | - |
| 393 | FBIO | Fortress Biotech, Inc. | 65.70M | 6.49% | 249,529 | 68.47M |
| 394 | CING | Cingulate Inc. | 64.57M | 4.23% | 56,652 | - |
| 395 | CLNN | Clene Inc. | 63.82M | 13.67% | 197,472 | 238.00K |
| 396 | CRDF | Cardiff Oncology, Inc. | 62.56M | 1.11% | 397,137 | 508.00K |
| 397 | SPRO | Spero Therapeutics, Inc. | 62.31M | 3.88% | 394,713 | 47.00M |
| 398 | VRCA | Verrica Pharmaceuticals Inc. | 61.84M | 12.85% | 35,946 | 30.32M |
| 399 | NORD | Nordicus Partners Corporation | 59.49M | -5.13% | 3,465 | - |
| 400 | XLO | Xilio Therapeutics, Inc. | 58.89M | 3.83% | 10,623 | 64.09M |
| 401 | XBIT | XBiotech Inc. | 57.32M | -0.53% | 14,540 | - |
| 402 | KLRS | Kalaris Therapeutics, Inc. | 56.89M | -1.24% | 72,759 | - |
| 403 | ALPS | Alps Group Inc | 55.91M | 1.91% | 44,503 | 3.74M |
| 404 | BOLD | Boundless Bio, Inc. | 55.73M | -0.41% | 29,953 | - |
| 405 | ANVS | Annovis Bio, Inc. | 55.68M | 6.25% | 5,159,509 | - |
| 406 | INKT | MiNK Therapeutics, Inc. | 54.70M | 3.57% | 9,829 | - |
| 407 | RNXT | RenovoRx, Inc. | 54.16M | 6.19% | 843,708 | 2.78M |
| 408 | RNTX | Rein Therapeutics Inc. | 53.77M | 1.56% | 317,588 | - |
| 409 | ELOX | Eloxx Pharmaceuticals, Inc. | 51.67M | 2.89% | 33,383 | - |
| 410 | TELO | Telomir Pharmaceuticals, Inc. | 51.53M | -1.42% | 170,155 | - |
| 411 | ONCY | Oncolytics Biotech Inc. | 50.83M | -9.29% | 1,133,096 | - |
| 412 | HYFT | MindWalk Holdings Corp. | 50.65M | 1.42% | 201,025 | 11.57M |
| 413 | IBIO | iBio, Inc. | 50.40M | 6.12% | 668,288 | 100.00K |
| 414 | PLRX | Pliant Therapeutics, Inc. | 49.74M | -0.80% | 288,543 | - |
| 415 | ATNM | Actinium Pharmaceuticals, Inc. | 49.36M | 9.79% | 465,820 | 35.09M |
| 416 | HOWL | Werewolf Therapeutics, Inc. | 49.09M | - | 334,522 | 21.00M |
| 417 | ATHE | Alterity Therapeutics Limited | 48.84M | 2.88% | 9,830 | 2.50M |
| 418 | GANX | Gain Therapeutics, Inc. | 47.79M | 6.31% | 302,129 | - |
| 419 | CNTB | Connect Biopharma Holdings Limited | 47.24M | 2.94% | 252,142 | 2.95M |
| 420 | MREO | Mereo BioPharma Group plc | 47.01M | 4.03% | 1,724,656 | 800.00K |
| 421 | ELTX | Elicio Therapeutics, Inc. | 46.99M | 9.93% | 219,011 | - |
| 422 | IMA | ImageneBio, Inc. | 45.75M | -1.83% | 14,772 | 800.00K |
| 423 | CRBU | Caribou Biosciences, Inc. | 44.84M | -7.51% | 3,255,132 | 9.44M |
| 424 | TIL | Instil Bio, Inc. | 44.15M | -4.69% | 32,084 | - |
| 425 | DWTX | Dogwood Therapeutics, Inc. | 43.96M | -10.16% | 147,811 | 100.00K |
| 426 | BMEA | Biomea Fusion, Inc. | 43.40M | 5.63% | 734,081 | - |
| 427 | APLM | Apollomics, Inc. | 42.82M | 2.63% | 9,121 | 413.00K |
| 428 | OSTX | OS Therapies Incorporated | 42.52M | -7.97% | 700,523 | - |
| 429 | LONA | LeonaBio, Inc. | 42.11M | 1.25% | 99,173 | - |
| 430 | HYPD | Hyperion DeFi, Inc. | 40.40M | 4.42% | 99,203 | 1.40M |
| 431 | GRCE | Grace Therapeutics, Inc. | 39.76M | 2.16% | 128,603 | - |
| 432 | GRDX | GridAI Technologies Corp. | 39.65M | 13.82% | 77,991 | - |
| 433 | ALDX | Aldeyra Therapeutics, Inc. | 38.01M | -0.57% | 753,332 | - |
| 434 | EXOZ | eXoZymes, Inc. | 37.78M | -7.50% | 26,308 | -700.00 |
| 435 | VERU | Veru Inc. | 37.25M | 3.07% | 134,124 | 16.89M |
| 436 | PMN | ProMIS Neurosciences, Inc. | 37.17M | -0.36% | 153,248 | - |
| 437 | IBO | Impact BioMedical Inc. | 36.99M | 5.61% | 4,378 | 35.00K |
| 438 | SER | Serina Therapeutics, Inc. | 36.83M | 5.07% | 91,346 | 130.00K |
| 439 | PTHS | Pelthos Therapeutics Inc. | 35.03M | -2.24% | 21,013 | 43.30M |
| 440 | INMB | INmune Bio Inc. | 34.75M | - | 544,199 | 50.00K |
| 441 | NNVC | NanoViricides, Inc. | 34.71M | 3.03% | 76,997 | - |
| 442 | IRLA | IRulya Therapeutics Inc. | 34.68M | 10.00% | 124,504 | - |
| 443 | EDSA | Edesa Biotech, Inc. | 33.64M | 16.36% | 83,721,299 | - |
| 444 | BCTX | BriaCell Therapeutics Corp. | 32.27M | -6.46% | 85,532 | - |
| 445 | ACET | Adicet Bio, Inc. | 31.86M | -2.95% | 174,755 | - |
| 446 | EYPT | EyePoint, Inc. | 30.86M | -0.58% | 3,897,171 | 2.79M |
| 447 | AARD | Aardvark Therapeutics, Inc. | 29.65M | 15.81% | 681,035 | - |
| 448 | NXTC | NextCure, Inc. | 28.97M | 18.76% | 57,483 | - |
| 449 | LITS | Lite Strategy, Inc. | 28.78M | -7.22% | 361,125 | - |
| 450 | ALGS | Aligos Therapeutics, Inc. | 27.79M | 9.34% | 141,096 | 33.65M |
| 451 | MGX | Metagenomi Therapeutics, Inc. | 27.52M | 2.68% | 132,446 | 13.56M |
| 452 | PLRZ | Polyrizon Ltd. | 26.98M | 0.59% | 6,604 | - |
| 453 | ABVC | ABVC BioPharma, Inc. | 26.74M | 6.32% | 26,926 | 797.92K |
| 454 | RNAZ | TransCode Therapeutics, Inc. | 26.07M | 3.36% | 16,152 | - |
| 455 | BYSI | BeyondSpring Inc. | 25.94M | 0.77% | 43,194 | 1.88M |
| 456 | CELU | Celularity Inc. | 24.94M | 1.11% | 151,122 | 18.67M |
| 457 | CVM | CEL-SCI Corporation | 24.27M | -4.83% | 52,686 | - |
| 458 | IMMP | Immutep Limited | 24.05M | 13.02% | 65,931 | 13.79M |
| 459 | FLNA | Filana Therapeutics, Inc. | 23.74M | 8.55% | 556,011 | - |
| 460 | EVAX | Evaxion A/S | 22.69M | -9.33% | 105,130 | 7.49M |
| 461 | ESLA | Estrella Immunopharma, Inc. | 21.93M | 34.32% | 3,858,279 | - |
| 462 | COCP | Cocrystal Pharma, Inc. | 21.77M | 8.65% | 62,169 | 330.00K |
| 463 | BSEM | BioStem Technologies, Inc. | 21.74M | 3.54% | 177,566 | 34.59M |
| 464 | CRVO | CervoMed Inc. | 21.48M | - | 314,094 | 8.73K |
| 465 | ATOS | Atossa Therapeutics, Inc. | 21.26M | 0.47% | 39,616 | - |
| 466 | IGC | IGC Pharma, Inc. | 20.94M | 1.25% | 390,068 | 1.11M |
| 467 | QNTM | Quantum BioPharma Ltd. | 19.05M | 6.89% | 76,181 | - |
| 468 | QNRX | Quoin Pharmaceuticals, Ltd. | 18.76M | 6.99% | 3,524 | - |
| 469 | TVRD | Tvardi Therapeutics, Inc. | 18.67M | 46.17% | 1,758,987 | - |
| 470 | ATYR | aTyr Pharma, Inc. | 18.39M | 18.11% | 184,384 | 190.00K |
| 471 | CNTX | Context Therapeutics Inc. | 18.16M | 2.17% | 706,370 | - |
| 472 | KTTA | Pasithea Therapeutics Corp. | 17.94M | -7.26% | 235,650 | - |
| 473 | BIVI | BioVie Inc. | 17.64M | -1.50% | 164,334 | - |
| 474 | ABOS | Acumen Pharmaceuticals, Inc. | 17.63M | 9.04% | 2,685,704 | - |
| 475 | ACTU | Actuate Therapeutics, Inc. | 17.62M | -2.59% | 300,033 | - |
| 476 | JSPR | Jasper Therapeutics, Inc. | 17.55M | -6.17% | 53,328 | - |
| 477 | MCRB | Seres Therapeutics, Inc. | 17.08M | -14.14% | 184,033 | 2.13M |
| 478 | AKTX | Akari Therapeutics, Plc | 16.91M | 0.41% | 41,714 | - |
| 479 | MRKR | Marker Therapeutics, Inc. | 16.84M | 13.13% | 231,449 | 3.55M |
| 480 | BOLT | Bolt Biotherapeutics, Inc. | 16.34M | -3.36% | 98,614 | 4.70M |
| 481 | KYNB | Kyntra Bio, Inc. | 15.79M | 4.56% | 11,103 | 4.62M |
| 482 | NCEL | NewcelX Ltd. | 15.60M | -0.90% | 21,353 | - |
| 483 | ALLR | Allarity Therapeutics, Inc. | 15.27M | -0.51% | 73,898 | 345.00K |
| 484 | NEUP | Neuphoria Therapeutics Inc. | 15.15M | 0.72% | 23,995 | 1.17M |
| 485 | PLUR | Pluri Inc. | 14.57M | -4.48% | 41,255 | 1.02M |
| 486 | CTXR | Citius Pharmaceuticals, Inc. | 14.46M | -3.39% | 265,333 | 7.11M |
| 487 | LPCN | Lipocine Inc. | 14.26M | 10.19% | 259,405 | 3.74M |
| 488 | DYAI | Dyadic International, Inc. | 14.03M | 13.27% | 109,912 | 3.80M |
| 489 | BCDA | BioCardia, Inc. | 13.96M | 8.48% | 117,877 | 3.00K |
| 490 | DARE | Daré Bioscience, Inc. | 13.34M | 6.12% | 94,646 | 1.37M |
| 491 | TCRX | TScan Therapeutics, Inc. | 12.39M | -2.77% | 669,228 | 7.11M |
| 492 | GUTS | Fractyl Health, Inc. | 12.00M | -2.67% | 275,817 | 3.00K |
| 493 | CLRB | Cellectar Biosciences, Inc. | 12.00M | 1.60% | 127,991 | - |
| 494 | PASG | Passage Bio, Inc. | 11.87M | -7.17% | 4,882 | - |
| 495 | PBM | Psyence Biomedical Ltd. | 11.65M | 3.21% | 28,404 | - |
| 496 | PTN | Palatin Technologies, Inc. | 11.18M | 7.50% | 155,186 | 13.19M |
| 497 | HIND | Vyome Holdings, Inc. | 10.88M | -1.90% | 9,806 | 129.73K |
| 498 | MTVA | MetaVia Inc. | 10.74M | 13.99% | 460,714 | - |
| 499 | PPBT | Purple Biotech Ltd | 10.73M | 2.29% | 37,265 | - |
| 500 | INTS | Intensity Therapeutics, Inc. | 10.58M | 8.00% | 56,050 | - |